NRCME Certified Medical Examiner Exam — Questions and Answers

Question 1: What is the clinical significance of finding persistent proteinuria (albumin 2+ or greater) on a DOT urinalysis in a commercial driver?

It automatically qualifies the driver for a 2-year certificate
It indicates the driver consumed excess protein before the exam
It is a normal finding in drivers over age 50
It may signal underlying renal disease requiring further evaluation (Correct answer)

Correct answer: It may signal underlying renal disease requiring further evaluation

Persistent proteinuria may indicate underlying chronic kidney disease or other renal pathology and requires further workup before certification.

Question 2: A commercial driver presents with Type 2 diabetes managed with insulin. His most recent HbA1c is 7.1%, and he reports one hypoglycemic episode three months ago requiring assistance from a coworker (no loss of consciousness). Under the Federal Diabetes Exemption Program, which of the following is the MOST accurate statement regarding his eligibility?

He must wait 6 months from the episode before applying, after which he is automatically eligible.
He may be eligible for an exemption if he has had no hypoglycemic episodes requiring assistance from another person within the past 12 months. (Correct answer)
He is permanently disqualified because he requires insulin and had a hypoglycemic episode requiring assistance within the past 12 months.
He qualifies immediately because his HbA1c is below 7.5% and no loss of consciousness occurred.

Correct answer: He may be eligible for an exemption if he has had no hypoglycemic episodes requiring assistance from another person within the past 12 months.

The Federal Diabetes Exemption Program requires, among other criteria, that the driver has had no hypoglycemic episodes requiring assistance from another person in the past 12 months. The episode described — requiring coworker assistance — occurred 3 months ago, placing him within that 12-month disqualifying window. HbA1c thresholds and absence of loss of consciousness alone do not override this requirement.

Question 3: When completing the MCSA-5875 (Federal Motor Carrier Safety Administration Medical Examination Report), which of the following represents a documentation error that could constitute grounds for medical examiner decertification?

Certifying a driver without recording the examining room blood pressure and pulse values, relying solely on a nurse-obtained triage reading taken 30 minutes prior (Correct answer)
Using 'WNL' (within normal limits) as a shorthand notation in the physical findings sections rather than writing out each finding individually
Leaving the 'medications' section blank when the driver reports taking only over-the-counter vitamins
Recording the urinalysis specific gravity without performing a dipstick protein or glucose analysis

Correct answer: Certifying a driver without recording the examining room blood pressure and pulse values, relying solely on a nurse-obtained triage reading taken 30 minutes prior

The MCSA-5875 requires the medical examiner — not ancillary staff — to perform and document the physical examination findings, including vital signs. Relying solely on a triage reading obtained by nursing staff without repeating or confirming vital signs during the actual examination constitutes a failure to personally perform the required examination. This can be grounds for decertification as it violates NRCME standards requiring the CME to personally conduct the examination. Using WNL shorthand is generally acceptable practice; leaving the vitamin section blank is minor; performing only specific gravity without other dipstick values may be incomplete but is not the most severe documentation violation listed.

Question 4: A 52-year-old commercial driver presents for DOT physical with a urine specific gravity of 1.003 and urine osmolality of 95 mOsm/kg. Serum sodium is 148 mEq/L. He denies excessive fluid intake. Which condition best explains this combination of findings?

Syndrome of inappropriate ADH with secondary water retention
Psychogenic polydipsia with dilutional hyponatremia
Nephrogenic diabetes insipidus with renal ADH resistance (Correct answer)
Central diabetes insipidus with impaired ADH secretion

Correct answer: Nephrogenic diabetes insipidus with renal ADH resistance

Nephrogenic diabetes insipidus (NDI) is characterized by the inability of the renal tubules to respond to ADH, resulting in dilute urine (low specific gravity, low osmolality) despite hypernatremia. Unlike central DI where exogenous ADH corrects the defect, NDI persists because the collecting duct receptors are unresponsive. Psychogenic polydipsia would cause dilute urine but also dilutional hyponatremia (not hypernatremia). Central DI would also produce dilute urine with hypernatremia, but ADH replacement would correct it. SIADH produces concentrated urine and hyponatremia—the opposite pattern.

Question 5: A CMV driver presents for recertification and reports a new diagnosis of ankylosing spondylitis (AS). Imaging shows grade 3 sacroiliitis and early bamboo spine changes at T12-L2. Current medications include an NSAID and a biologic. He denies uveitis or cardiac involvement. On exam, lumbar flexion is severely limited (Schober test: +1 cm), cervical rotation is 35° bilaterally, and lateral bending is 20° bilaterally. He reports no falls in the past year. The MOST medically accurate basis for the examiner's decision is:

AS with bamboo spine changes is an absolute disqualifier under FMCSA musculoskeletal regulations
Biologic therapy for AS is a disqualifying medication under FMCSA drug and alcohol regulations
Because AS is a progressive autoimmune condition, only a 1-year certificate is permissible regardless of current functional status
The combination of severely limited cervical rotation (35°) and lumbar flexibility raises a significant functional concern about the driver's ability to safely check mirrors and blind spots, warranting careful functional assessment before certification (Correct answer)

Correct answer: The combination of severely limited cervical rotation (35°) and lumbar flexibility raises a significant functional concern about the driver's ability to safely check mirrors and blind spots, warranting careful functional assessment before certification

AS is not an absolute disqualifier under FMCSA regulations, but the physical findings here are clinically significant. Cervical rotation of 35° (normal ~80°) is severely restricted and directly impairs the driver's ability to safely check mirrors, merge, and perform blind-spot checks — core CMV safety tasks. Schober test of +1 cm indicates minimal lumbar mobility. The examiner must weigh whether these deficits prevent safe CMV operation. A functional capacity evaluation or road test referral may be warranted. Biologics are not listed as disqualifying medications; FMCSA's drug/alcohol rules address controlled substances, not prescription biologics.

Question 6: When evaluating a driver on bupropion for depression, the medical examiner should be most aware of which potential side effect relevant to driving?

Peripheral neuropathy
Lowered seizure threshold at high doses (Correct answer)
Severe hypertension requiring monitoring
Excessive sedation

Correct answer: Lowered seizure threshold at high doses

Bupropion can lower the seizure threshold, particularly at higher doses, which is a significant safety concern for CMV drivers.

Question 7: Under current FMCSA regulations, within what timeframe must a National Registry-certified medical examiner electronically transmit the results of a completed commercial driver medical examination — including whether the driver was certified or not — to the FMCSA National Registry system?

Within 7 calendar days of completing the examination
Within 3 business days of completing the examination
Within 24 hours of completing the examination (Correct answer)
By the end of the same calendar day as the examination

Correct answer: Within 24 hours of completing the examination

FMCSA regulations require certified medical examiners to transmit examination results electronically to the National Registry within 24 hours of completing the examination, regardless of outcome. This applies to all examinations — including those resulting in non-certification. The 24-hour rule ensures near-real-time data integrity in the national driver qualification system and supports enforcement and audit functions. Examiners who fail to transmit within 24 hours are in violation of their registry obligations even if the physical examination itself was properly conducted.

Question 8: A driver presents with a diagnosis of long QT syndrome (LQTS), confirmed on genetic testing (LQT1 subtype). He is currently on nadolol and has had no syncopal episodes or arrhythmic events in 4 years. His corrected QT interval (QTc) on his most recent ECG is 468 ms. How should the medical examiner approach this case?

Disqualify the driver permanently; LQTS is a genetic channelopathy associated with sudden cardiac death risk in commercial drivers (Correct answer)
Certify the driver for 2 years; a QTc below 500 ms with beta-blocker therapy is within acceptable limits per FMCSA
Certify for 1 year with mandatory annual cardiology review, as controlled LQTS on beta-blockers may be certifiable
Require the driver to undergo ICD implantation prior to any certification consideration

Correct answer: Disqualify the driver permanently; LQTS is a genetic channelopathy associated with sudden cardiac death risk in commercial drivers

LQTS, including the LQT1 subtype, carries an inherent risk of malignant ventricular arrhythmias (torsades de pointes) and sudden cardiac death. FMCSA advisory criteria and cardiovascular specialist consensus generally consider genetic channelopathies associated with life-threatening arrhythmic risk — even when asymptomatic on treatment — as disqualifying for commercial motor vehicle operation. Unlike acquired QT prolongation that resolves with medication changes, LQTS is a permanent structural susceptibility. The current asymptomatic status does not eliminate the unpredictable risk of sudden incapacitation. ICD implantation is not a prerequisite for disqualification; the underlying diagnosis itself is the basis.

Question 9: A 55-year-old driver fails the forced whisper test during his recertification exam. Which of the following is the most appropriate next step for the medical examiner to take?

Require the driver to obtain a hearing aid and repeat the whisper test
Certify the driver for 3 months pending re-evaluation
Refer the driver for an audiometric test (Correct answer)
Disqualify the driver immediately

Correct answer: Refer the driver for an audiometric test

If a driver fails the whisper test, the regulations allow for an alternative test. The driver must be referred for an audiometric test. If the driver passes the audiometric test, they can be qualified.

Question 10: A 45-year-old driver reports a new diagnosis of hypertrophic cardiomyopathy (HCM). The driver is asymptomatic and provides a letter from their cardiologist. Which of the following findings would allow the medical examiner to consider certification?

No history of sustained ventricular tachycardia. (Correct answer)
A family history of sudden death in a first-degree relative.
Left ventricular septum thickness of 32 mm.
A history of syncope.

Correct answer: No history of sustained ventricular tachycardia.

While HCM was previously disqualifying, current guidelines allow for certification if the driver is considered low-risk. Low-risk criteria include no history of cardiac arrest, no spontaneous sustained ventricular tachycardia, no syncope, no family history of premature sudden death, and a left ventricular septum thickness of less than 30mm. The absence of sustained ventricular tachycardia is one of the key low-risk indicators.

Question 11: Hyperthyroidism in a commercial driver raises concern primarily because untreated cases may cause which safety-relevant symptom?

Chronic fatigue syndrome
Severe hypertension alone
Cardiac arrhythmias and tremor affecting safe driving (Correct answer)
Peripheral neuropathy

Correct answer: Cardiac arrhythmias and tremor affecting safe driving

Untreated hyperthyroidism can cause atrial fibrillation, tremor, and hyperactivity — all of which may impair a driver's ability to safely operate a commercial vehicle.

Question 12: A driver has a horizontal field of vision of 65 degrees in the right eye and 75 degrees in the left eye. What certification decision should be made?

Refer for vision exemption program
Certify with annual monitoring of the right eye
Certify; the combined field exceeds 70 degrees
Disqualify; the right eye fails the 70-degree minimum (Correct answer)

Correct answer: Disqualify; the right eye fails the 70-degree minimum

FMCSA requires at least 70 degrees of horizontal field in each eye; the right eye at 65 degrees does not meet this standard.

Question 13: When evaluating a driver who had a myocardial infarction (MI), the NRCME examiner must consider which key functional assessment?

Left ventricular ejection fraction (LVEF) post-recovery (Correct answer)
Number of vessels involved in the coronary event
Total cholesterol level after the MI
Serum troponin levels at the time of examination

Correct answer: Left ventricular ejection fraction (LVEF) post-recovery

LVEF is a primary determinant of post-MI cardiac function and risk stratification; FMCSA advisory criteria reference adequate cardiac reserve for certification.

Question 14: A 57-year-old CDL holder has a well-documented prior history of severe alcohol use disorder. He has been abstinent for 14 months, verified by quarterly PEth levels (all undetectable), regular AA attendance, and a psychiatrist's letter confirming sustained early remission with no current AUD diagnosis. His physical examination is otherwise unremarkable. Under 49 CFR 391.41(b)(13), which of the following is the most accurate statement regarding certification?

The driver qualifies automatically after 12 months of verified sobriety under FMCSA safe harbor provisions for alcohol-related conditions
The driver is permanently disqualified; any documented history of severe AUD is a lifetime bar under FMCSA regulations
The driver cannot be certified without completing an FMCSA-approved neuropsychological battery to rule out alcohol-related cognitive impairment
The driver may be certified; the FMCSA standard requires absence of a CURRENT clinical diagnosis of alcoholism, and documented remission can support qualification (Correct answer)

Correct answer: The driver may be certified; the FMCSA standard requires absence of a CURRENT clinical diagnosis of alcoholism, and documented remission can support qualification

49 CFR 391.41(b)(13) disqualifies drivers with a 'current clinical diagnosis of alcoholism' — the operative word is 'current.' A prior history of severe AUD does not permanently disqualify a driver if the condition is in documented remission at the time of examination. With 14 months of verified sobriety through objective biomarker testing (PEth), psychiatric documentation of remission, and a clean physical exam, the ME can certify the driver — typically with a shorter certification period (1 year) and monitoring conditions. There are no FMCSA 'safe harbor provisions' for automatic qualification at 12 months. Neuropsychological testing is not universally required. Permanent disqualification for AUD history alone is a common misconception about FMCSA standards.

Question 15: A medical examiner finds 3+ protein and 2+ glucose on a driver's urinalysis during the DOT physical. What is the most appropriate course of action?

Certify for 1 year and recheck at next exam
Defer certification pending further evaluation of both findings (Correct answer)
Issue a 90-day certificate without further workup
Certify immediately because these findings are common in truck drivers

Correct answer: Defer certification pending further evaluation of both findings

Combined significant proteinuria and glycosuria suggest serious underlying pathology (e.g., diabetic nephropathy) requiring complete evaluation before certification can be responsibly issued.

Question 16: When evaluating a driver with peripheral neuropathy, the medical examiner's primary concern should be whether the condition:

Causes intermittent pain in the extremities.
Requires the use of over-the-counter pain medication.
Is a result of poorly controlled diabetes mellitus.
Interferes with the safe operation and control of a commercial motor vehicle. (Correct answer)

Correct answer: Interferes with the safe operation and control of a commercial motor vehicle.

While the cause and symptoms of peripheral neuropathy are important, the ultimate determination for medical certification rests on whether the condition, specifically any motor or sensory deficits, interferes with the driver's ability to safely control the vehicle. This includes assessing strength, sensation, position sense, and reflexes necessary for operating foot pedals and maintaining control.

Question 17: Which of the following findings related to diabetic retinopathy is considered an absolute and permanent disqualification for a commercial motor vehicle driver?

Severe nonproliferative or proliferative diabetic retinopathy. (Correct answer)
A history of laser photocoagulation therapy.
Absence of retinopathy but a diagnosis of diabetes for over 10 years.
Mild background diabetic retinopathy.

Correct answer: Severe nonproliferative or proliferative diabetic retinopathy.

FMCSA regulations permanently disqualify any driver diagnosed with severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy. These conditions present a significant and unpredictable risk of sudden vision loss, which is incompatible with the safe operation of a CMV.

Question 18: A medical examiner is assessing a driver who sustained a lumbar burst fracture (L2) 18 months ago, treated with posterior spinal fusion L1-L3. He has returned to work as an office employee, is neurologically intact, has no radiculopathy, and reports 4/10 chronic low back pain on exertion. His physiatrist notes 'functional for sedentary to light work.' What should guide the examiner's certification decision MOST directly?

The pain score: any chronic pain rated above 3/10 is disqualifying under FMCSA musculoskeletal standards
The 18-month post-surgical interval, which exceeds the FMCSA-mandated 12-month waiting period for spinal fusion
The physiatrist's 'light work' restriction, which categorically excludes commercial driving under FMCSA guidelines
An individualized assessment of whether the driver can safely perform all physical demands of CMV operation, including emergency egress, sustained vibration tolerance, and load securement (Correct answer)

Correct answer: An individualized assessment of whether the driver can safely perform all physical demands of CMV operation, including emergency egress, sustained vibration tolerance, and load securement

FMCSA has no mandated waiting period after spinal fusion — the 12-month figure does not exist in the regulations. 'Light work' functional capacity designations from occupational medicine or physiatry use a different taxonomy than CMV operation demands and do not categorically disqualify a driver. There is no numeric pain threshold in the regulations. The correct standard is individualized functional evaluation: can this specific driver safely perform the full scope of CMV operation — including prolonged vibration exposure, emergency vehicle egress, load securement, and sustained postural demands — given his current physical status? The examiner may request functional capacity evaluation or physiatry re-evaluation using CMV-specific physical demands as the reference standard.

Question 19: Under FMCSA regulations, a commercial driver with a blood pressure reading of 160/100 mmHg at the time of examination should be:

Disqualified permanently
Certified for 1 year with follow-up required (Correct answer)
Certified for 2 years with no follow-up
Certified for 3 years with no restrictions

Correct answer: Certified for 1 year with follow-up required

Stage 2 hypertension (160-179/100-109 mmHg) permits a one-time certification of up to 12 months, requiring treatment and follow-up to confirm BP control.

Question 20: Which urinalysis finding is most consistent with a urinary tract infection (UTI) in a commercial driver during a DOT physical?

Glucose 1+ with no protein
Specific gravity of 1.025
Specific gravity of 1.005 only
Positive nitrites and leukocyte esterase (Correct answer)

Correct answer: Positive nitrites and leukocyte esterase

Positive nitrites (indicating bacterial reduction) and leukocyte esterase (indicating white blood cells) are classic dipstick markers of a urinary tract infection.

Question 21: A driver presents with monocular vision due to enucleation of the left eye and has held a valid CMV license for 3 years. How should the examiner proceed?

Disqualify; monocular vision automatically disqualifies all drivers
Issue a 90-day certificate while awaiting specialist clearance
Evaluate for the FMCSA Vision Exemption Program if the driver fails the standard (Correct answer)
Certify without restriction under the grandfather clause exemption

Correct answer: Evaluate for the FMCSA Vision Exemption Program if the driver fails the standard

Monocular drivers who cannot meet the vision standard may apply for the FMCSA Vision Exemption Program, which allows qualified drivers to continue operating CMVs.

Question 22: Pheochromocytoma poses a disqualifying risk for commercial drivers primarily because it can cause what sudden event?

Progressive hearing loss
Chronic fatigue
Paroxysmal hypertensive crisis causing incapacitation (Correct answer)
Peripheral neuropathy

Correct answer: Paroxysmal hypertensive crisis causing incapacitation

Pheochromocytoma can trigger sudden, severe hypertensive crises with palpitations, sweating, and headache that may cause sudden incapacitation while operating a vehicle.

Question 23: A CDL holder's FMCSA medical certificate expires on a Monday. Due to a scheduling conflict, the driver operates a commercial motor vehicle on Tuesday before obtaining a new certificate. Under FMCSA regulations, which statement most accurately describes the driver's legal status on Tuesday?

The driver is immediately disqualified upon certificate expiration; operating on Tuesday constitutes a violation with no grace period under federal law (Correct answer)
The driver has a 10-day federal grace period before their disqualification takes effect
The driver may operate for up to 30 days while a new examination is being scheduled, provided the prior certificate was not revoked for medical cause
The driver's CDL automatically converts to a Class D license on expiration, allowing continued operation of lighter CMVs pending renewal

Correct answer: The driver is immediately disqualified upon certificate expiration; operating on Tuesday constitutes a violation with no grace period under federal law

There is no federal grace period for an expired medical certificate. Under 49 CFR 391.41, a driver must be physically qualified at all times while operating a CMV, and a valid medical certificate is a component of that qualification. The moment the certificate expires, the driver is no longer medically qualified and any subsequent CMV operation is a federal violation. Additionally, under 49 CFR 383.71, states are required to downgrade the CDL of any holder who fails to maintain a current medical certificate — there is no transitional operating privilege at the federal level.

Question 24: A truck driver is diagnosed with sudden unilateral vision loss in the right eye. After treatment, right eye corrected acuity is 20/80 and left eye corrected acuity is 20/30. What is the correct course of action?

Certify if the driver passes a behind-the-wheel evaluation
Disqualify; the right eye fails the vision standard (Correct answer)
Certify with a 1-year certificate and ophthalmologic monitoring
Issue a 90-day conditional certificate for observation

Correct answer: Disqualify; the right eye fails the vision standard

Corrected acuity of 20/80 in the right eye does not meet the FMCSA standard of 20/40 in each eye, requiring disqualification.

Question 25: Which arterial blood gas pattern most strongly suggests chronic respiratory failure in a driver with advanced COPD?

PaO2 85 mmHg, PaCO2 38 mmHg, pH 7.41
PaO2 58 mmHg, PaCO2 52 mmHg, pH 7.36 with elevated HCO3 (Correct answer)
PaO2 90 mmHg, PaCO2 44 mmHg, pH 7.39
PaO2 70 mmHg, PaCO2 30 mmHg, pH 7.48

Correct answer: PaO2 58 mmHg, PaCO2 52 mmHg, pH 7.36 with elevated HCO3

Hypoxemia with hypercapnia and compensatory metabolic alkalosis (elevated bicarbonate, near-normal pH) indicates chronic ventilatory failure.

Question 26: A driver holds a federal vision exemption for monocular vision (left eye is non-functional). At today's examination, corrected visual acuity in the functional right eye measures 20/50 — down from 20/30 at the prior examination. The driver's federal exemption is current and was issued based on meeting 20/40 or better in the functional eye. What is the correct action for the medical examiner?

Certify for 12 months because the federal exemption covers any monocular vision scenario
Issue a 3-month certificate to allow the driver to obtain updated corrective lenses and return for recheck
Determine the driver does not currently meet the conditions of the exemption and issue a not-physically-qualified determination (Correct answer)
Continue certification and notify FMCSA of the acuity change within 30 days via the NRCME portal

Correct answer: Determine the driver does not currently meet the conditions of the exemption and issue a not-physically-qualified determination

Federal vision exemptions are issued based on specific criteria, including that the driver meets 20/40 corrected acuity in the functioning eye. If the driver's acuity in the functional eye drops below 20/40, the driver no longer satisfies the conditions under which the exemption was granted. The medical examiner cannot unilaterally extend or reinterpret the exemption — the driver must be found not physically qualified. The driver would need to return to FMCSA to seek modification or renewal of the exemption. Issuing a short-term certificate does not resolve the underlying non-compliance with exemption criteria.

Question 27: A commercial driver with well-controlled hypertension (BP 132/84 on two antihypertensives) undergoes an echocardiogram for an unrelated complaint. The report shows moderate concentric left ventricular hypertrophy (LVH) with preserved ejection fraction. He denies chest pain, dyspnea, palpitations, or syncope. How should the NRCME examiner most appropriately handle this finding?

The finding of LVH as a marker of hypertensive end-organ damage warrants further cardiovascular evaluation before finalizing certification, and may affect the certification period (Correct answer)
The driver is disqualified because LVH is an absolute contraindication under FMCSA cardiovascular standards
The driver should be automatically certified for 1 year since BP is controlled and there is no functional impairment
LVH with preserved EF and no symptoms is incidental and does not affect certification

Correct answer: The finding of LVH as a marker of hypertensive end-organ damage warrants further cardiovascular evaluation before finalizing certification, and may affect the certification period

LVH is a recognized marker of hypertensive end-organ damage that significantly elevates the risk of future adverse cardiovascular events, including arrhythmia, heart failure, and sudden cardiac death — all relevant to commercial driving safety. NRCME guidelines require the examiner to consider overall cardiovascular risk, not just BP numbers in isolation. Moderate LVH warrants specialist input (e.g., cardiology) to fully characterize the driver's risk before certification is finalized, and the certification period may be shortened based on specialist findings.

Question 28: During a DOT medical examination, a driver discloses he was prescribed zolpidem (Ambien) for insomnia 3 nights per week and last took it 14 hours before the examination. His sleep diary shows he averages 6.5 hours of sleep on nights he uses the medication. Under FMCSA medical standards, which action is most appropriate?

Certify the driver for one year since zolpidem is not on the FMCSA list of Schedule I substances
Defer certification and counsel the driver that zolpidem use is incompatible with CMV operation due to residual sedation risk, pending evaluation of underlying sleep disorder (Correct answer)
Issue a 3-month certificate conditioned on a sleep study, since the medication implies possible obstructive sleep apnea
Disqualify the driver because Schedule IV hypnotics are categorically prohibited for CMV operators under 49 CFR 391.41

Correct answer: Defer certification and counsel the driver that zolpidem use is incompatible with CMV operation due to residual sedation risk, pending evaluation of underlying sleep disorder

Zolpidem is not categorically prohibited by a specific FMCSA regulatory list, but the FMCSA Medical Advisory Criteria and the Medical Examiner Handbook state that sedating medications — including hypnotics — may impair driving safety and must be evaluated for residual effects and underlying cause. Zolpidem has a documented residual sedation risk (especially extended-release formulations) and the FDA has issued warnings about next-morning impairment. The ME should defer certification, address the underlying sleep complaint (which may include OSA or other disorder), and advise that ongoing use of sedating hypnotics is incompatible with safe CMV operation. Conditioning a certificate on a sleep study without addressing the medication use itself is insufficient.

Question 29: A driver with a unilateral hearing aid in the left ear undergoes audiometric testing. The right ear (better, unaided) shows 45 dB average hearing loss. The left ear with the hearing aid shows 32 dB average hearing loss. The driver fails the unaided whisper test at 5 feet in both ears but passes it at 4 feet in the aided left ear. What is the correct certification outcome?

Disqualify the driver because the unaided right ear (better unaided ear) exceeds 40 dB and whisper testing fails at 5 feet in both ears
Certify the driver with a requirement to wear the hearing aid while driving and note this on the medical certificate
Certify the driver because the aided left ear audiometric result of 32 dB meets the ≤40 dB standard (Correct answer)
Disqualify the driver because whisper testing must be passed without any assistive device

Correct answer: Certify the driver because the aided left ear audiometric result of 32 dB meets the ≤40 dB standard

The FMCSA hearing standard assesses the 'better ear' with OR without a hearing aid. In this case, the better ear for the audiometric standard is the aided left ear at 32 dB — which meets the ≤40 dB threshold. The standard explicitly allows hearing aids. The unaided right ear result (45 dB) is irrelevant because the standard permits the use of a hearing aid and evaluates the result in the better ear under the aided condition. The driver passes via the audiometric pathway using the aided left ear. The ME should note on the certificate that the driver relies on a hearing aid.

Question 30: What is the primary pharmacological mechanism by which naltrexone reduces alcohol craving?

Serotonin reuptake inhibition, improving mood independent of drinking
GABA-A potentiation, replacing the sedative effect of alcohol
Dopamine agonism, stabilizing reward pathways
Opioid receptor blockade, reducing the rewarding effects of alcohol (Correct answer)

Correct answer: Opioid receptor blockade, reducing the rewarding effects of alcohol

Naltrexone blocks mu-opioid receptors, which reduces the euphoric and reinforcing effects of alcohol and decreases craving.

Question 31: During a medical examination, a driver discloses that he takes alprazolam (Xanax) 0.5 mg PRN for 'occasional anxiety' prescribed by his family doctor. He reports last taking it 3 days ago and denies daily use. What is the MOST accurate FMCSA guidance-based conclusion?

PRN use of a low-dose benzodiazepine is permissible as long as the driver does not take it within 24 hours of driving
The driver is disqualified under 49 CFR 391.41(b)(12) solely because alprazolam is a CNS depressant
The driver qualifies for certification because 0.5 mg is below the therapeutic threshold for impairment
Alprazolam is a Schedule IV benzodiazepine that FMCSA considers potentially disqualifying regardless of dose; the ME should obtain more information about frequency, functional impact, and the underlying anxiety disorder before certifying (Correct answer)

Correct answer: Alprazolam is a Schedule IV benzodiazepine that FMCSA considers potentially disqualifying regardless of dose; the ME should obtain more information about frequency, functional impact, and the underlying anxiety disorder before certifying

FMCSA does not specify a per se safe dose or dose-free interval for benzodiazepines. The advisory criteria flag all benzodiazepines as potentially disqualifying due to sedation, impaired reaction time, and anterograde amnesia risks. Additionally, PRN use implies an underlying anxiety disorder that itself must be evaluated for driving safety. The ME must assess the diagnosis, frequency of actual use, driving behavior, and whether the driver has ever driven while medicated. There is no FMCSA-endorsed '24-hour rule' for alprazolam.

Question 32: An ITDM-exempt CMV driver submits his annual renewal documentation. His endocrinologist's report notes one episode of mild hypoglycemia (BG 62 mg/dL) that he self-treated with juice while off duty, no severe episodes, stable retinopathy (non-proliferative, mild), and HbA1c of 7.8%. His ophthalmologist confirms best-corrected visual acuity of 20/30 in the right eye and 20/40 in the left eye. What is the MOST appropriate action by the medical examiner?

Deny renewal of the medical certificate because the driver fails the federal distant visual acuity standard of 20/40 in each eye with both eyes open at 20/40 or better, and 20/40 in the better eye alone
Issue a 3-month certificate rather than 12 months due to the progressive nature of diabetic retinopathy
Renew the certificate; mild hypoglycemia, non-proliferative retinopathy, and 20/40 vision meet all ITDM exemption renewal criteria (Correct answer)
Defer certification pending repeat ophthalmology evaluation in 3 months to assess retinopathy progression

Correct answer: Renew the certificate; mild hypoglycemia, non-proliferative retinopathy, and 20/40 vision meet all ITDM exemption renewal criteria

The FMCSA distant visual acuity standard requires 20/40 or better in each eye and both eyes open — this driver's 20/30 (right) and 20/40 (left) both meet the 20/40 threshold. The single self-treated mild hypoglycemic episode off duty is not a severe episode and does not trigger disqualification. Mild non-proliferative retinopathy does not itself disqualify, provided acuity standards are met. There is no FMCSA rule mandating a shortened certificate solely for stable NPDR. Renewal is appropriate.

Question 33: A driver reports a single unprovoked seizure 6 months ago with no recurrence and is currently on antiepileptic medication. What is the FMCSA standard?

Certify with a 3-month certificate
Disqualify; must be seizure-free for 10 years off medication to qualify (Correct answer)
Certify if seizure-free for 6 months on medication
Certify if EEG is normal

Correct answer: Disqualify; must be seizure-free for 10 years off medication to qualify

FMCSA requires drivers to be seizure-free for 10 years off anticonvulsant medications to meet interstate CMV standards.

Question 34: Which blood pressure threshold constitutes Stage 3 (severe) hypertension requiring disqualification under FMCSA guidelines?

≥160 systolic or ≥100 diastolic
≥140 systolic or ≥90 diastolic
≥150 systolic or ≥95 diastolic
≥180 systolic or ≥110 diastolic (Correct answer)

Correct answer: ≥180 systolic or ≥110 diastolic

Blood pressure of 180/110 mmHg or higher is Stage 3 hypertension and disqualifies a driver from certification until it is treated and confirmed below that threshold.

Question 35: A driver applying for a vision exemption must submit which type of supporting documentation to FMCSA?

An ophthalmologist or optometrist evaluation confirming vision status and driving safety (Correct answer)
No additional documentation; the examiner's notes suffice
A letter from their primary care physician
A state DMV vision screening result only

Correct answer: An ophthalmologist or optometrist evaluation confirming vision status and driving safety

A vision exemption application requires a specialist evaluation from an ophthalmologist or optometrist documenting the driver's vision status and safety to operate.

Question 36: An NRCME examiner is evaluating a driver with a BMI of 41 who is otherwise healthy. Blood pressure is 124/78 mmHg, fasting glucose is 98 mg/dL. What should the examiner document regarding obesity?

Issue a 1-year certificate contingent on weight loss
Certify with no restrictions; obesity alone is not a disqualifying condition (Correct answer)
Certify only after a sleep study rules out OSA
Permanently disqualify; BMI over 40 is disqualifying under FMCSA rules

Correct answer: Certify with no restrictions; obesity alone is not a disqualifying condition

Obesity alone without associated disqualifying conditions (e.g., uncontrolled hypertension, diabetes, OSA) does not disqualify a CMV driver under current FMCSA standards.

Question 37: Which metabolic condition is most commonly associated with obstructive sleep apnea in commercial drivers, creating a dual disqualifying concern for the NRCME examiner?

Obesity with metabolic syndrome (Correct answer)
Hypothyroidism
Addison's disease
Type 1 diabetes

Correct answer: Obesity with metabolic syndrome

Obesity with metabolic syndrome is strongly associated with OSA, and both conditions independently affect driver safety and certification.

Question 38: During a DOT physical, a commercial driver reports progressive morning stiffness lasting over 2 hours and bilateral sacroiliac joint tenderness. Imaging reveals grade 3 sacroiliitis. He is currently asymptomatic during driving. What is the MOST appropriate action for the NRCME examiner?

Certify for 1 year with mandatory follow-up imaging
Disqualify permanently due to progressive inflammatory spinal disease
Certify for 2 years, as he is currently asymptomatic during vehicle operation
Defer certification pending rheumatology consultation to assess disease activity, medication effects, and functional driving capacity (Correct answer)

Correct answer: Defer certification pending rheumatology consultation to assess disease activity, medication effects, and functional driving capacity

Advanced sacroiliitis consistent with ankylosing spondylitis raises multiple concerns beyond current symptoms: disease progression may limit spinal and cervical rotation needed for mirror checks and lane changes; immunosuppressive or biologic medications (e.g., TNF inhibitors) can cause fatigue, dizziness, or infection-related acute illness. The examiner lacks sufficient information to certify safely without rheumatology input on disease activity trajectory and medication profile. Certifying on symptom status alone ignores these risks; permanent disqualification without functional assessment is also inappropriate.

Question 39: A medical examiner is evaluating a driver who operates a school bus transporting 24 school-age children. Which CMV category does this vehicle fall under for certification purposes?

It requires only a state-level medical certificate, not a federal DOT certificate
It qualifies as a CMV because it is designed to transport more than 8 passengers for compensation or as a for-hire vehicle (Correct answer)
It is not a CMV because school buses are exempt from FMCSA medical standards
It is only a CMV if the GVWR exceeds 26,001 lbs

Correct answer: It qualifies as a CMV because it is designed to transport more than 8 passengers for compensation or as a for-hire vehicle

A vehicle designed to transport more than 8 passengers (excluding the driver) for compensation is classified as a CMV under FMCSA regulations, triggering federal medical certification requirements regardless of vehicle weight. A school bus transporting 24 children clearly meets this definition, requiring the driver to hold a valid FMCSA medical examiner's certificate.

Question 40: Under the FMCSA insulin-treated diabetes mellitus (ITDM) exemption program, at which intervals must a driver measure blood glucose while operating a commercial motor vehicle?

Within 1 hour before driving, every 2 hours while driving, and after completing the drive (Correct answer)
Once before the start of each driving shift only
Before and after each delivery stop, regardless of elapsed time
Every 4 hours during driving and once upon completing the shift

Correct answer: Within 1 hour before driving, every 2 hours while driving, and after completing the drive

The FMCSA ITDM exemption program requires drivers to measure blood glucose within 1 hour before operating a CMV, every 2 hours during operation, and after completing the drive. If glucose falls below 80 mg/dL, the driver must not operate the vehicle until the level is safely restored and stable. This strict protocol is designed to detect hypoglycemia before it impairs driving performance.

Question 41: Which of the following statements regarding alcohol use by a CMV driver is correct according to FMCSA regulations found in 49 CFR §392.5?

A driver with a blood alcohol concentration (BAC) of 0.03% must be removed from safety-sensitive duties for 24 hours. (Correct answer)
A driver may consume alcohol up to one hour before going on duty.
A driver is permitted to have one alcoholic beverage in their possession while on duty as long as it is unopened.
A driver who consumes alcohol on duty must be taken out of service for 12 hours.

Correct answer: A driver with a blood alcohol concentration (BAC) of 0.03% must be removed from safety-sensitive duties for 24 hours.

According to 49 CFR §382.505, a driver with a confirmed alcohol concentration of 0.02% or greater but less than 0.04% must be immediately removed from safety-sensitive functions for at least 24 hours. Consuming alcohol within four hours of going on duty is prohibited, and possession is not allowed unless it is part of a manifested cargo shipment. A BAC of 0.04% or greater is a violation requiring the full return-to-duty process.

Question 42: A CMV driver with newly diagnosed insulin-treated diabetes mellitus (ITDM) has stabilized their condition. According to FMCSA standards, what is the primary requirement before the Certified Medical Examiner (CME) can consider certification?

The driver must be evaluated by an FMCSA-appointed endocrinologist.
The driver must complete a mandatory 6-month waiting period without any hypoglycemic events.
The driver must have their treating clinician complete the Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5870. (Correct answer)
The driver must first obtain a Skills Performance Evaluation (SPE) certificate.

Correct answer: The driver must have their treating clinician complete the Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5870.

The current FMCSA process requires that the driver's own treating clinician (TC) evaluates their diabetes management and completes the MCSA-5870 form. The CME then uses this form, which must be completed within 45 days of the exam, to help make the certification decision.

Question 43: A CMV driver with severe OSA (baseline AHI 52) underwent uvulopalatopharyngoplasty (UPPP) 8 months ago. He discontinued CPAP post-surgery, believing the procedure cured him. No post-operative sleep study has been performed. He presents for medical certification. What is the most appropriate action?

Disqualify until post-operative polysomnography confirms adequate OSA resolution (Correct answer)
Accept the surgeon's operative notes as sufficient documentation of treatment success
Certify for 1 year given that 8 months have elapsed since surgery, providing adequate healing time
Issue a 90-day conditional certificate while awaiting post-operative polysomnography results

Correct answer: Disqualify until post-operative polysomnography confirms adequate OSA resolution

Surgical treatment for OSA does not guarantee cure. UPPP has an AHI normalization success rate of approximately 40–50%, and outcomes can change over time. Without objective post-operative polysomnography, the medical examiner cannot confirm OSA is adequately controlled. A 90-day conditional certificate is inappropriate because no objective data exists yet — the driver must first provide documentation of treatment efficacy, not the other way around.

Question 44: Which DOT-mandated test type is triggered when a driver is involved in a fatal accident while operating a CMV?

Random testing under the existing pool selection
Pre-employment retesting regardless of prior test results
Post-accident testing, which must occur within 8 hours for alcohol and 32 hours for drugs (Correct answer)
Reasonable suspicion testing based on behavioral observations

Correct answer: Post-accident testing, which must occur within 8 hours for alcohol and 32 hours for drugs

Post-accident testing is required following a fatal accident; alcohol testing must occur within 8 hours and drug testing within 32 hours.

Question 45: A driver who holds a valid FMCSA Vision Exemption returns for recertification. His exempt eye now has worsened to no light perception. What action should the examiner take?

Renew the certificate; the exemption covers the driver regardless of changes
Disqualify and instruct the driver to reapply for a new exemption
Certify because the exemption is permanent once granted
Notify FMCSA and evaluate whether the exemption conditions are still met (Correct answer)

Correct answer: Notify FMCSA and evaluate whether the exemption conditions are still met

Changes in the driver's medical condition must be reported and evaluated; the examiner should notify FMCSA and determine whether the driver still meets the conditions of the exemption.

Question 46: The FMCSA recommends that medical examiners use which tool to systematically screen commercial drivers for OSA risk?

A multivariate risk assessment combining BMI, neck circumference, and symptoms (Correct answer)
Overnight oximetry as the sole screening method
The Berlin Questionnaire exclusively
The STOP-BANG questionnaire exclusively

Correct answer: A multivariate risk assessment combining BMI, neck circumference, and symptoms

FMCSA guidance endorses using multiple risk factors—including BMI, neck circumference, blood pressure, and reported symptoms—rather than any single tool alone.

Question 47: A 44-year-old commercial driver presents for a DOT physical with documentation from his addiction medicine specialist confirming 2 years of stable methadone maintenance therapy (MMT) for opioid use disorder, consistently negative urine drug screens (excluding methadone), and no behavioral concerns. He requests full certification. What is the correct FMCSA determination?

Certify for 6 months with semi-annual follow-up from the addiction specialist
The driver is not medically qualified to operate a CMV while on methadone maintenance therapy (Correct answer)
Defer certification and request a 90-day functional driving assessment before deciding
Certify for 1 year; a physician's letter documenting stability is sufficient to qualify the driver

Correct answer: The driver is not medically qualified to operate a CMV while on methadone maintenance therapy

Under FMCSA guidelines, drivers using methadone — a Schedule II controlled substance — for opioid maintenance therapy are not medically qualified to operate CMVs, regardless of therapeutic stability, duration of sobriety, or specialist documentation. The agency's position is that adequate safety data does not exist to support certification of drivers on opioid maintenance therapy. Physician clearance letters do not override this disqualification. This same principle extends to buprenorphine-based maintenance therapies.

Question 48: Under FMCSA guidance, a CMV driver found to be using amphetamines not prescribed by a licensed physician for a legitimate medical condition is:

Required to undergo 6 months of monitored sobriety before recertification
Eligible for a skills performance evaluation waiver
Issued a warning and reassessed in 90 days
Medically disqualified (Correct answer)

Correct answer: Medically disqualified

Non-prescribed stimulant use is a disqualifying condition under FMCSA drug and alcohol standards.

Question 49: A commercial driver presents for a DOT physical with a resting blood pressure of 152/96 mmHg. He reports being on a new antihypertensive medication for three weeks but forgot its name. After re-measurement, BP is 149/94 mmHg. Which of the following correctly describes the certification action and required follow-up?

Certify for two years because Stage 1 hypertension does not require shortened certification periods under current FMCSA guidelines
Certify for one year and require a follow-up BP check within 12 months to confirm medication efficacy
Issue a one-time 3-month certificate to allow treatment stabilization, after which a full 2-year certification requires BP below 140/90 mmHg (Correct answer)
Disqualify the driver until written documentation of the antihypertensive medication name and dosage is obtained from the prescribing physician

Correct answer: Issue a one-time 3-month certificate to allow treatment stabilization, after which a full 2-year certification requires BP below 140/90 mmHg

FMCSA guidelines classify BP 140-159/90-99 as Stage 1 hypertension. The driver is currently in Stage 1 (marginally, confirmed on re-test) but has newly initiated treatment. The correct protocol is a one-time 3-month certificate. If at the follow-up visit BP is below 140/90 mmHg, a full 2-year certificate can be issued. Documentation of medication name is helpful but not a disqualifying prerequisite — the examiner can note 'antihypertensive, unknown name per driver' on the form.

Question 50: A driver with diabetic retinopathy has undergone laser treatment and now has corrected acuity of 20/40 in each eye but reduced peripheral vision of 55 degrees in each eye. What is the appropriate action?

Issue a 1-year certificate with ophthalmic follow-up
Certify if the driver demonstrates safe driving history
Disqualify; peripheral vision fails to meet the 70-degree requirement (Correct answer)
Certify; visual acuity meets the standard

Correct answer: Disqualify; peripheral vision fails to meet the 70-degree requirement

Despite meeting acuity standards, peripheral vision of 55 degrees per eye fails the FMCSA minimum of 70 degrees, resulting in disqualification.

Question 51: A 48-year-old Type 1 diabetic CMV driver managed via insulin pump has a HbA1c of 7.1% and no history of severe hypoglycemic episodes requiring third-party assistance in the past 12 months. However, his endocrinologist documents confirmed hypoglycemia unawareness with multiple asymptomatic glucose readings below 55 mg/dL. What is the correct certification decision?

Certify for 1 year with mandatory continuous glucose monitor (CGM) usage
Disqualify — hypoglycemia unawareness is disqualifying regardless of HbA1c or absence of severe episodes (Correct answer)
Issue a 90-day certificate while awaiting updated endocrinology documentation
Certify for 6 months pending repeat evaluation of hypoglycemia awareness

Correct answer: Disqualify — hypoglycemia unawareness is disqualifying regardless of HbA1c or absence of severe episodes

Hypoglycemia unawareness is an absolute disqualifying condition under the FMCSA ITDM exemption framework. Even if a driver has excellent glycemic control (low HbA1c) and no prior severe episodes, the inability to perceive warning signs of hypoglycemia means the driver cannot self-identify and respond to a dangerous glucose drop while operating a CMV. Good CGM data or HbA1c values do not override this disqualifier.

Question 52: A commercial truck driver is newly diagnosed with moderate obstructive sleep apnea (apnea-hypopnea index of 22 events/hour) and prescribed CPAP therapy. He reports no current daytime sleepiness. The medical examiner is considering the certification path. Which approach best reflects current FMCSA guidance on OSA and CMV certification?

The driver may not be certified under any circumstances until 12 continuous months of documented CPAP compliance have been verified
Since the driver denies daytime sleepiness, no treatment compliance documentation is required; issue a standard 2-year certificate
OSA is a federally listed disqualifying condition requiring an FMCSA waiver before any certificate can be issued
The driver may receive a time-limited certificate after demonstrating adequate CPAP adherence — typically ≥4 hours/night on ≥70% of nights — and requires annual re-examination to confirm ongoing compliance (Correct answer)

Correct answer: The driver may receive a time-limited certificate after demonstrating adequate CPAP adherence — typically ≥4 hours/night on ≥70% of nights — and requires annual re-examination to confirm ongoing compliance

OSA is not a per se disqualifying condition under FMCSA regulations, and no formal waiver program exists for it. However, FMCSA guidance — consistent with the NRCME evidence report — requires that drivers with moderate-to-severe OSA demonstrate adequate treatment adherence before certification. 'Adequate adherence' generally mirrors CMS standards: ≥4 hours/night on ≥70% of nights. The certificate should be time-limited (typically 1 year), and objective CPAP data (not self-report) must be reviewed at re-examination. The absence of subjective sleepiness alone is insufficient, as OSA can impair performance without perceived symptoms.

Question 53: During a DOT physical, a driver reveals he was recently prescribed supplemental oxygen at 2 L/min for nocturnal hypoxemia related to obesity hypoventilation syndrome (OHS), but has not yet seen a pulmonologist. His FVC is 68% predicted and FEV1/FVC ratio is 0.82. What is the correct certification approach?

Certify for two years since OHS is not listed as a disqualifying condition in 49 CFR Part 391
Certify for one year because his FEV1/FVC ratio above 0.70 rules out obstructive disease
Disqualify pending evaluation by a pulmonologist and documentation that the underlying condition is stable and safely managed (Correct answer)
Certify with a 90-day certificate because oxygen supplementation is a temporary measure

Correct answer: Disqualify pending evaluation by a pulmonologist and documentation that the underlying condition is stable and safely managed

OHS is a serious condition involving chronic hypoventilation, hypercapnia, and hypoxemia that extends beyond simple OSA. A driver requiring supplemental oxygen for nocturnal hypoxemia has not yet established stability of the condition, and the reduced FVC (68%) indicates restrictive physiology consistent with obesity-related chest wall restriction. FMCSA standards require that any respiratory condition that interferes with oxygenation sufficient to impair safe driving must be evaluated. Without specialist input confirming stability and adequate daytime oxygenation without supplemental O2 during driving, certification cannot be granted. The absence of OHS from explicit 49 CFR disqualifiers does not override the general standard for respiratory fitness.

Question 54: What is the significance of detecting muscle atrophy in one lower extremity during a NRCME exam?

It is expected in long-haul drivers and requires no action
It may indicate chronic nerve compression, disuse, or neurological disease affecting that limb's strength (Correct answer)
Muscle atrophy is a normal aging finding with no safety implications
It is relevant only if the driver reports pain in that limb

Correct answer: It may indicate chronic nerve compression, disuse, or neurological disease affecting that limb's strength

Unilateral muscle atrophy can signal chronic radiculopathy, peripheral nerve injury, or other neurological disease, which may affect limb strength and driving safety.

Question 55: A commercial driver with diabetes is found to have microalbuminuria. This is most relevant to the examiner because it indicates:

Retinal hemorrhage risk within 30 days
Increased risk of seizure
Peripheral nerve damage only
Early diabetic kidney disease and elevated cardiovascular risk (Correct answer)

Correct answer: Early diabetic kidney disease and elevated cardiovascular risk

Microalbuminuria signals early nephropathy and is a marker of systemic vascular disease that elevates overall cardiovascular risk.

Question 56: What is the primary physiological mechanism causing hypertension in untreated obstructive sleep apnea?

Fluid retention from nocturnal hypoventilation
Increased cardiac output from hypoxia-induced tachycardia
Repetitive sympathetic nervous system activation during apneic events (Correct answer)
Elevated cortisol from chronic stress

Correct answer: Repetitive sympathetic nervous system activation during apneic events

Repetitive apneic events trigger surges in sympathetic tone, raising catecholamines and causing sustained hypertension even during waking hours.

Question 57: A CDL applicant presents with corrected distant visual acuity of 20/30 in the right eye and 20/50 in the left eye. The applicant argues that their combined binocular acuity is well within acceptable range. What is the correct FMCSA/NRCME determination?

Disqualified — both eyes must individually meet the 20/40 threshold, regardless of binocular acuity (Correct answer)
Qualified — binocular acuity is the operative standard under 49 CFR 391.41
Referred — the examiner should consult an ophthalmologist before making a determination
Qualified with restriction — driver must wear corrective lenses at all times

Correct answer: Disqualified — both eyes must individually meet the 20/40 threshold, regardless of binocular acuity

Under 49 CFR 391.41(b)(10), distant visual acuity of at least 20/40 (Snellen) must be met in EACH eye separately, with or without corrective lenses. There is no provision that allows a weaker eye to be offset by a stronger one — the 20/50 left eye independently disqualifies this driver. Binocular averaging is not recognized under federal standards.

Question 58: A CMV driver with a pacemaker implanted for atrioventricular (AV) block is seeking recertification. What is the maximum certification period for this driver, assuming their underlying condition is stable and they have cardiologist clearance?

One year
Six months
Three years
Two years (Correct answer)

Correct answer: Two years

Drivers with pacemakers for conditions like AV block or sinus node dysfunction who are stable and have clearance from their cardiologist can be certified for a maximum of one year. Annual recertification is necessary to ensure the pacemaker is functioning correctly and the underlying cardiac condition remains stable.

Question 59: Which document must a commercial driver physically carry while operating a CMV to demonstrate medical fitness?

The MCSA-5875 Medical Examination Report
The MCSA-5876 Medical Examiner's Certificate (Correct answer)
Their state driver's license with a medical waiver stamp
A printed copy of the National Registry listing for their examiner

Correct answer: The MCSA-5876 Medical Examiner's Certificate

Drivers must carry the MCSA-5876 Medical Examiner's Certificate (or a copy) while operating a CMV as proof of current medical certification.

Question 60: An examiner is evaluating a 55-year-old driver with a prior history of lung cancer treated with right upper lobe lobectomy 3 years ago. He is currently in complete remission confirmed by oncology. Spirometry shows FEV1 of 62% predicted, FVC of 78% predicted, and FEV1/FVC ratio of 0.72. He is asymptomatic at rest and with mild exertion. What is the most appropriate certification decision?

Disqualify permanently due to prior malignancy history
Refer to a respiratory specialist and defer certification until an exercise tolerance test confirms no exertional oxygen desaturation (Correct answer)
Issue a one-year certificate with requirement for annual pulmonary function testing
Certify for up to two years if no other disqualifying conditions are present, since remission is confirmed and the driver is functionally asymptomatic

Correct answer: Refer to a respiratory specialist and defer certification until an exercise tolerance test confirms no exertional oxygen desaturation

FMCSA regulations (49 CFR 391.41(b)(5)) require that a driver not have a current clinical diagnosis of a respiratory dysfunction likely to interfere with safe vehicle control. An FEV1 of 62% predicted represents moderate obstruction (GOLD Stage II), and the post-lobectomy anatomy means baseline reserve is reduced. While remission status is favorable, exertional oxygen desaturation is a key safety concern in this population. An exercise tolerance test (e.g., 6-minute walk with oximetry, or formal cardiopulmonary exercise testing) objectively confirms whether desaturation occurs under conditions relevant to driving demands. Permanent disqualification based on prior malignancy alone is not FMCSA policy. Annual spirometry without functional testing does not adequately address the safety question. Certifying without objective exertional data is premature given the moderate obstruction.

Question 61: Which of the following best describes FMCSA's approach to hearing aid use by commercial drivers?

Hearing aids are prohibited in CMV operation
Drivers using hearing aids must obtain a separate federal waiver
Hearing aids are permitted but their use is not documented on the medical certificate
Hearing aids may be used to meet the hearing standard, and drivers must wear them while driving (Correct answer)

Correct answer: Hearing aids may be used to meet the hearing standard, and drivers must wear them while driving

FMCSA permits hearing aids to meet the whispered voice standard; if needed, drivers must wear the aid while operating and this restriction is noted on the certificate.

Question 62: Which of the following clinical presentations would MOST appropriately result in a one-time 3-month conditional certificate under NRCME hypertension standards, rather than full-period certification or disqualification?

A driver with BP 192/116 currently on three antihypertensive agents
A driver with BP 154/96 who was certified at the Stage 1 threshold at the previous annual exam
A driver with BP 168/106 on first presentation, never previously treated for hypertension (Correct answer)
A driver with BP 138/88 on no medications and no prior hypertension diagnosis

Correct answer: A driver with BP 168/106 on first presentation, never previously treated for hypertension

Stage 2 hypertension (160–179 systolic / 100–109 diastolic) on first presentation is the specific scenario designed for the one-time 3-month conditional certificate — allowing the driver to initiate treatment, achieve control, and return for reassessment. Answer A (BP 138/88) does not meet the hypertension threshold; answer C (BP 192/116) represents Stage 3 hypertension, which results in disqualification rather than a conditional certificate; answer D (Stage 1, 154/96) qualifies for a 1-year certificate, not a 3-month conditional one.

Question 63: Which condition would most likely require a vision specialist's evaluation before a medical examiner can certify a commercial driver?

20/30 uncorrected vision correctable to 20/20
Mild myopia requiring reading glasses
Mild astigmatism corrected to 20/40
Recent cataract surgery with implanted intraocular lens (Correct answer)

Correct answer: Recent cataract surgery with implanted intraocular lens

Recent eye surgery may affect stability of vision and the examiner should consider specialist consultation to ensure the driver's vision has stabilized at or above the required standard.

Question 64: A 45-year-old driver is newly diagnosed with severe OSA (AHI > 30) and begins CPAP treatment. He is eager to return to work. After demonstrating effective treatment and resolution of sleepiness, what is the earliest a medical examiner can typically issue an initial conditional certification?

After 30 days of compliant use
After 90 days of compliant use
After 1 week of compliant use (Correct answer)
After 1 day of compliant use

Correct answer: After 1 week of compliant use

For a driver newly starting CPAP treatment, a medical examiner may issue a short conditional certification after a minimum period of demonstrated use, which is typically one week. This allows the driver to return to work while continuing to gather the 30-90 days of compliance data needed for a longer-term certification.

Question 65: A driver diagnosed with monocular vision (enucleation of right eye) has been operating CMVs interstate under a Federal Vision Exemption for 3 years without incident. The exemption is current. During routine re-certification, the medical examiner notes no new findings. What is the appropriate action?

Decline to certify — monocular drivers are permanently disqualified and no exemption can override 49 CFR 391.41
Issue a 1-year certificate with a note requiring ophthalmological clearance at each renewal
Issue a 2-year certificate — monocular drivers with active exemptions are treated identically to fully sighted drivers for certification duration purposes
Issue a 1-year certificate — the Federal Vision Exemption substitutes for the regulatory vision standard and the examiner must otherwise certify normally (Correct answer)

Correct answer: Issue a 1-year certificate — the Federal Vision Exemption substitutes for the regulatory vision standard and the examiner must otherwise certify normally

A valid Federal Vision Exemption issued by FMCSA legally permits a driver who cannot meet the standard binocular vision requirement to operate CMVs in interstate commerce. The medical examiner's role is to confirm that the driver otherwise meets all other physical qualification standards and that the exemption is current. The certificate is issued for the standard maximum period (up to 2 years), but in practice FMCSA's exemption program typically conditions renewals annually. The examiner does not independently require ophthalmological documentation beyond what the exemption program itself mandates — adding extra conditions outside the exemption scope is not the examiner's prerogative.

Question 66: During evaluation of a 61-year-old interstate truck driver, the ME discovers he had a TIA 4 months ago with full neurological recovery. He is now on dual antiplatelet therapy. CT angiography shows no significant stenosis. His neurologist has cleared him to return to driving. What should the ME do?

Certify for 2 years since TIAs are transient and leave no permanent deficit by definition
Deny certification until 12 months have passed from the TIA event, regardless of recovery (Correct answer)
Certify for 1 year with annual neurology follow-up, since full recovery and specialist clearance are documented
Issue a 3-month certificate while monitoring for recurrence before committing to annual certification

Correct answer: Deny certification until 12 months have passed from the TIA event, regardless of recovery

FMCSA guidance treats TIA as a serious cerebrovascular event with high short-term stroke recurrence risk. While TIAs cause no permanent deficits by definition, the ME must consider whether the underlying vascular condition creates an ongoing risk of sudden incapacitation. The standard approach requires at least 12 months from the event before certification can be considered, even with full recovery and specialist clearance, to allow adequate time to assess recurrence risk and vascular stability.

Question 67: A commercial driver is taking clonidine 0.3 mg twice daily for hypertension. His in-office BP is 126/80 mmHg. He mentions that he sometimes forgets his midday dose when on long hauls. Which of the following represents the most clinically significant concern the NRCME examiner should document regarding this driver's medication regimen?

Clonidine is explicitly prohibited under FMCSA regulations for commercial drivers due to its sedative profile
Missing doses of clonidine can trigger hypertensive rebound, potentially reaching Stage 3 levels and causing hypertensive emergency (Correct answer)
Long-term clonidine use results in progressive weight gain that may disqualify the driver under BMI standards
Clonidine causes fluid retention, requiring periodic BMP monitoring to assess renal function

Correct answer: Missing doses of clonidine can trigger hypertensive rebound, potentially reaching Stage 3 levels and causing hypertensive emergency

Clonidine is a centrally acting alpha-2 agonist that suppresses sympathetic outflow. Abrupt discontinuation or missed doses — particularly at higher doses — can trigger severe rebound hypertension, sometimes exceeding the original pretreatment BP and reaching Stage 3 (≥180/110 mmHg) or causing hypertensive crisis. This is especially concerning for long-haul drivers who may miss doses while on the road. Additionally, clonidine's sedative CNS effects can impair alertness, but the rebound phenomenon is the most acutely dangerous issue. Clonidine is not explicitly prohibited by FMCSA, but compliance and side-effect risks must be carefully documented by the examiner.

Question 68: Which of the following would NOT disqualify a commercial driver under FMCSA vision standards?

Horizontal field of 60 degrees in the left eye
Monocular vision with 20/40 acuity in the one functioning eye
Inability to distinguish red from green traffic signals
Corrected acuity of 20/40 in each eye with normal color perception (Correct answer)

Correct answer: Corrected acuity of 20/40 in each eye with normal color perception

Corrected acuity of 20/40 in each eye with normal color perception meets all FMCSA vision requirements for certification.

Question 69: A driver with hyperparathyroidism presents with serum calcium of 11.8 mg/dL and complaints of fatigue and difficulty concentrating. What is the most appropriate NRCME action?

Certify for 2 years; calcium of 11.8 is borderline
Certify for 1 year with repeat labs
Refer to nephrology only
Disqualify until hypercalcemia is treated and symptoms resolve (Correct answer)

Correct answer: Disqualify until hypercalcemia is treated and symptoms resolve

Symptomatic hypercalcemia causes cognitive impairment and fatigue that directly compromise driving safety, warranting disqualification until treated.

Question 70: When a driver disagrees with a medical examiner's disqualifying determination due to a psychological condition, the driver's appropriate recourse is:

Demand the examiner certify under protest
Request a state DMV override of the federal determination
File a complaint with the FMCSA and seek evaluation by another NRCME-certified examiner (Correct answer)
Obtain a waiver directly from their motor carrier employer

Correct answer: File a complaint with the FMCSA and seek evaluation by another NRCME-certified examiner

Drivers may seek review through FMCSA processes or obtain evaluation from another certified medical examiner; the carrier cannot override a medical disqualification.

Question 71: A driver with a history of Stage 3 hypertension was previously disqualified. He returns 4 months later on antihypertensive therapy with a BP of 136/86 mmHg. Assuming no other disqualifying conditions, what is the maximum certification period the medical examiner may issue?

2 years
1 year (Correct answer)
6 months
3 months

Correct answer: 1 year

Although a driver with no cardiovascular history and normal BP may receive a 2-year certificate, a driver returning after disqualification for Stage 3 hypertension is limited to a 1-year certificate, even when BP is now controlled below 140/90. FMCSA guidance treats this as a monitored recertification cycle requiring annual follow-up. The 2-year maximum does not apply once Stage 3 has been documented.

Question 72: What is the minimum horizontal visual field requirement in each eye for FMCSA commercial driver certification?

50 degrees
70 degrees (Correct answer)
60 degrees
80 degrees

Correct answer: 70 degrees

FMCSA requires at least 70 degrees of peripheral vision in the horizontal meridian in each eye.

Question 73: Which of the following scenarios most clearly warrants disqualification under FMCSA cardiovascular standards due to risk of sudden incapacitation?

Hypertrophic obstructive cardiomyopathy with syncope in the past year (Correct answer)
Mild mitral valve prolapse with no regurgitation
Surgically corrected atrial septal defect with normal function
Well-controlled hypertension on a single antihypertensive agent

Correct answer: Hypertrophic obstructive cardiomyopathy with syncope in the past year

Hypertrophic obstructive cardiomyopathy with recent syncope represents a high risk for sudden cardiac death and incapacitation, which disqualifies the driver.

Question 74: A driver reports taking warfarin for atrial fibrillation with an INR consistently maintained between 2.0 and 3.0. The NRCME examiner should:

Consider certification based on the underlying cardiac condition and overall risk assessment (Correct answer)
Require the driver to stop warfarin for 30 days before examination
Certify only if the driver switches to aspirin instead
Automatically disqualify the driver because anticoagulation is a hazard in crashes

Correct answer: Consider certification based on the underlying cardiac condition and overall risk assessment

Anticoagulation therapy alone is not disqualifying; the examiner must evaluate the underlying condition (atrial fibrillation) and whether it poses a risk of sudden incapacitation.

Question 75: A 52-year-old CMV driver with a BMI of 31 presents with an Epworth Sleepiness Scale (ESS) score of 7 and an AHI of 14 on home sleep testing. He denies excessive daytime sleepiness and his employer reports no safety incidents. Under FMCSA guidance, what is the most appropriate certification decision?

Certify for one year with the requirement to provide documentation of follow-up evaluation in 90 days (Correct answer)
Disqualify until he completes a full in-lab polysomnography confirming the AHI result
Certify for two years because his ESS is below the threshold of 10 and he has no reported incidents
Issue a one-time 90-day certificate and require PAP therapy adherence documentation before renewal

Correct answer: Certify for one year with the requirement to provide documentation of follow-up evaluation in 90 days

An AHI of 14 places this driver in the mild OSA range (AHI 5–14.9). The ESS of 7 is below the clinical cutoff of 10 for excessive daytime sleepiness. FMCSA guidance recommends certification with a reduced interval (typically one year rather than two) for mild OSA, contingent on follow-up documentation confirming stable management or lack of progression. Disqualification is not warranted for mild OSA without demonstrated impairment, and a 90-day certificate is reserved for moderate-to-severe cases requiring treatment initiation.

Question 76: Under FMCSA regulations, a driver with a diagnosis of schizophrenia is generally:

Disqualified because antipsychotics impair reaction time
Medically disqualified due to the unpredictable nature of the condition (Correct answer)
Eligible for a 1-year certificate with monitoring
Required to obtain a special exemption from the state DMV

Correct answer: Medically disqualified due to the unpredictable nature of the condition

Schizophrenia is considered disqualifying under FMCSA guidance due to the potential for sudden incapacitation and unpredictable symptom exacerbation.

Question 77: A 51-year-old driver is applying for certification and discloses a history of opioid use disorder treated with buprenorphine/naloxone (Suboxone) for 3 years under MOUD (medications for opioid use disorder). He is clinically stable, employed full-time outside of driving, and has no positive tests or relapses. His physician states he is in 'medically supported remission.' What does current FMCSA regulatory guidance state about this driver's eligibility?

The driver is categorically disqualified because buprenorphine is a Schedule III opioid and any scheduled opioid use disqualifies CMV operators under 49 CFR 391.41(b)(12) (Correct answer)
The driver is eligible for a 1-year certificate only, with mandatory quarterly drug screens arranged by the ME
The driver must be off buprenorphine for at least 12 months before the medical examiner can consider certification
The driver is eligible for certification if the medical examiner determines the medication does not impair safe driving, consistent with the 2022 FMCSA MOUD guidance

Correct answer: The driver is categorically disqualified because buprenorphine is a Schedule III opioid and any scheduled opioid use disqualifies CMV operators under 49 CFR 391.41(b)(12)

As of the current FMCSA regulatory framework, drivers using methadone or buprenorphine for MOUD remain categorically disqualified from interstate CMV operation. FMCSA's 2022 MOUD guidance acknowledged the evolving landscape and called for further study, but did NOT change the disqualification standard — it directed an evidence review, not a policy change. The agency has not issued a final rule permitting MOUD drivers. Under 49 CFR 391.41(b)(12), a driver must not use any Schedule I substance or any amphetamine, narcotic, or habit-forming drug. Buprenorphine (Schedule III) falls under 'narcotic' in this context, and FMCSA has consistently maintained disqualification for MOUD patients pending rulemaking.

Question 78: A driver taking theophylline for COPD management reports palpitations and tremor. These symptoms are most relevant to the NRCME exam because they suggest:

Normal side effects that do not affect driving fitness
Theophylline toxicity, which may cause cardiac arrhythmias disqualifying the driver (Correct answer)
Need to switch to inhaled therapy only if symptoms are mild
Anxiety disorder requiring psychiatric clearance before certification

Correct answer: Theophylline toxicity, which may cause cardiac arrhythmias disqualifying the driver

Theophylline has a narrow therapeutic index; toxicity can precipitate serious arrhythmias, seizures, and syncope that directly endanger commercial vehicle operation.

Question 79: When a driver's mental health condition is well-controlled and the treating psychiatrist recommends certification, the medical examiner's final determination should be based on:

The totality of clinical evidence including the specialist's input (Correct answer)
The psychiatrist's recommendation alone
An independent federal waiver program decision
The driver's self-reported symptom score

Correct answer: The totality of clinical evidence including the specialist's input

The medical examiner must integrate all available information and bears the ultimate responsibility for the certification decision.

Question 80: A driver with known coronary artery disease asks about the NRCME requirement for exercise stress testing. Under FMCSA advisory criteria, stress testing is recommended to demonstrate:

That the driver's resting ECG is normal prior to exertion
Freedom from any ST-segment changes at any level of exertion
Adequate functional capacity (generally ≥ 6 METs) without significant ischemia or arrhythmia (Correct answer)
That the driver can achieve a target heart rate of 220 minus age

Correct answer: Adequate functional capacity (generally ≥ 6 METs) without significant ischemia or arrhythmia

FMCSA advisory criteria recommend demonstrating adequate functional capacity (≥6 METs) without ischemia or significant arrhythmia on stress testing for CAD patients seeking certification.

Question 81: Which blood pressure reading at the time of the DOT physical examination would require the driver to be recertified in 12 months rather than 24 months?

145/90 mmHg
150/95 mmHg
160/100 mmHg (Correct answer)
130/85 mmHg

Correct answer: 160/100 mmHg

Stage 1 hypertension (140-159/90-99 mmHg) at the time of examination results in a one-time certification of 12 months; 160/100 falls in Stage 2 range requiring additional evaluation.

Question 82: A 40-year-old driver experienced a single, unprovoked seizure 6 years ago. He has been off all anti-seizure medication for the entire 6-year period and has had no further episodes. He provides a comprehensive evaluation from his neurologist clearing him. What is the maximum certification period for this driver?

2 years
6 months
1 year (Correct answer)
Disqualified

Correct answer: 1 year

According to FMCSA guidelines, a driver with a history of a single unprovoked seizure may be qualified if they have been seizure-free and off anti-seizure medication for a 5-year period or more. However, due to the nature of the condition, more frequent monitoring is required. Therefore, the maximum certification period for such a driver is one year.

Question 83: Which of the following best describes a condition that would warrant referral to a specialist before issuing a medical certificate for musculoskeletal concerns?

Mild bilateral knee crepitus without pain
Progressive muscle weakness of unclear etiology affecting lower extremities (Correct answer)
History of resolved plantar fasciitis
A well-healed ankle fracture from 10 years prior with full functional recovery

Correct answer: Progressive muscle weakness of unclear etiology affecting lower extremities

Progressive lower extremity weakness of unclear cause requires specialist evaluation to rule out serious neurological or systemic disease before certification.

Question 84: When a driver with diabetes reports using a continuous glucose monitor (CGM), the examiner should understand that:

CGM data must be submitted to FMCSA monthly
CGM is a monitoring tool and does not change FMCSA qualification requirements (Correct answer)
CGM replaces the need for finger-stick checks under exemption protocols
CGM use automatically qualifies the driver for exemption

Correct answer: CGM is a monitoring tool and does not change FMCSA qualification requirements

CGM is a useful monitoring device but does not alter the legal qualification framework; drivers must still meet all FMCSA standards.

Question 85: A 52-year-old CMV driver is referred for a sleep study due to a BMI of 38, a neck circumference of 18 inches, and reports of daytime sleepiness. The polysomnography reveals an Apnea-Hypopnea Index (AHI) of 28 events per hour. According to FMCSA guidance and common sleep medicine classifications, how is this driver's condition categorized?

Normal, no treatment required
Moderate Obstructive Sleep Apnea (OSA) (Correct answer)
Severe Obstructive Sleep Apnea (OSA)
Mild Obstructive Sleep Apnea (OSA)

Correct answer: Moderate Obstructive Sleep Apnea (OSA)

The Apnea-Hypopnea Index (AHI) is used to classify the severity of sleep apnea. An AHI of 5-14 is mild, 15-29 is moderate, and 30 or greater is severe. An AHI of 28 falls into the moderate category, which requires treatment for a CMV driver to be medically certified.

Question 86: A CMV driver's urinalysis shows a specific gravity of 1.001. Which condition does this most likely indicate?

Chronic kidney disease
Urinary tract infection
Dehydration
Diabetes insipidus or overhydration (Correct answer)

Correct answer: Diabetes insipidus or overhydration

A specific gravity of 1.001 indicates very dilute urine, consistent with diabetes insipidus or excessive fluid intake.

Question 87: A 47-year-old male long-haul driver presents for a DOT physical. BMI is 40, neck circumference is 18.5 inches. He denies snoring, witnessed apneas, or excessive daytime sleepiness. His wife reportedly confirms no observed apneas. He has never been evaluated for obstructive sleep apnea (OSA). The driver asks for a 2-year certificate. What is the MOST defensible approach?

Issue a certificate of shorter duration, document the objective risk factors, and provide a strong recommendation for OSA evaluation before recertification (Correct answer)
Issue a 2-year certificate, since the driver denies all classic OSA symptoms and no objective testing is required without clinical diagnosis
Refuse to examine the driver until he completes an in-lab polysomnography study
Issue a 2-year certificate contingent on the driver returning an Epworth Sleepiness Scale score of 10 or below within 60 days

Correct answer: Issue a certificate of shorter duration, document the objective risk factors, and provide a strong recommendation for OSA evaluation before recertification

No FMCSA regulation mandates OSA testing for all high-risk drivers, but the medical examiner bears responsibility for identifying conditions likely to interfere with safe driving. A BMI ≥35 and neck circumference ≥17 inches (male) represent objective high-risk features for OSA — a condition associated with increased crash risk. Symptom self-report is unreliable, as many OSA patients lack insight into their sleepiness. The defensible approach is to certify for a reduced period (commonly 1 year), clearly document the risk factors, and direct the driver to undergo OSA evaluation before recertification. Refusing to examine without prior PSG is unsupported by regulation.

Question 88: A commercial driver undergoing a DOT physical has a urinalysis positive for blood (hematuria). What should the medical examiner do?

Ignore the finding if the driver reports no symptoms
Disqualify the driver permanently
Investigate the cause of hematuria before making a certification decision (Correct answer)
Certify the driver for 1 year and schedule a follow-up

Correct answer: Investigate the cause of hematuria before making a certification decision

Hematuria must be investigated to rule out significant urologic or renal pathology before the examiner can make an appropriate certification decision.

Question 89: When completing the abdominal section of the physical examination for a CMV driver, what is the medical examiner primarily looking for that is relevant to driver fitness?

Bowel sounds to screen for irritable bowel syndrome
Dietary compliance in drivers with diabetes
Hepatomegaly, splenomegaly, abnormal masses, or hernias that may indicate conditions affecting driver safety (Correct answer)
Evidence of colorectal cancer by palpation

Correct answer: Hepatomegaly, splenomegaly, abnormal masses, or hernias that may indicate conditions affecting driver safety

During the abdominal examination, the ME is looking for findings such as hepatomegaly or splenomegaly (suggesting underlying liver or hematologic disease), abnormal masses, tenderness suggesting active disease, and hernias—any of which may indicate conditions that could impair driver safety or signal systemic disease requiring further evaluation.

Question 90: When assessing a driver's hands and fingers, which two functions are critical for determining physical qualification under 49 CFR 391.41(b)(2)?

Supination and pronation.
Adduction and abduction.
Prehension and power grasping. (Correct answer)
Fine motor dexterity and flexion.

Correct answer: Prehension and power grasping.

The regulation at 49 CFR 391.41(b)(2)(i) specifically states that a person is physically qualified if they have no impairment of a hand or finger which interferes with 'prehension or power grasping'. These functions are essential for safely manipulating a steering wheel, shifting gears, and operating other vehicle controls. The other options describe movements, but are not the specific functional abilities cited in the regulation.

Question 91: Under 49 CFR 391.41, a driver must have distant visual acuity of at least:

20/20 in each eye with or without correction
20/30 in the better eye only
20/40 in each eye with or without correction (Correct answer)
20/50 in one eye and 20/100 in the other

Correct answer: 20/40 in each eye with or without correction

FMCSA requires at least 20/40 acuity in each eye with or without corrective lenses.

Question 92: What is the minimum pre-driving blood glucose level recommended for insulin-treated exempt CMV drivers before operating a CMV?

60 mg/dL
100 mg/dL (Correct answer)
80 mg/dL
140 mg/dL

Correct answer: 100 mg/dL

Insulin-treated exempt drivers are generally advised to confirm blood glucose is at least 100 mg/dL before driving.

Question 93: A driver with a past opioid use disorder has been in full sustained remission for 4 years, is no longer on any medications, and has no relapses. What is the FMCSA's stance on certification?

The driver must have a 10-year remission period before re-certification is considered
The driver may be certified if the medical examiner determines the condition is well-controlled and poses no driving safety risk (Correct answer)
The driver can only be certified for intrastate operations
The driver is permanently disqualified once an opioid use disorder diagnosis is documented

Correct answer: The driver may be certified if the medical examiner determines the condition is well-controlled and poses no driving safety risk

FMCSA advisory criteria allow certification when a history of substance use disorder is in full remission and the medical examiner determines there is no current safety risk.

Question 94: A CMV driver enrolled in the FMCSA Insulin-Treated Diabetes Mellitus (ITDM) exemption program experiences a blood glucose reading of 88 mg/dL during a mandatory self-monitoring check while on duty. He treats with fast-acting carbohydrates and his glucose rises to 112 mg/dL. Under FMCSA exemption program requirements, what is the MINIMUM additional condition that must be met before he may resume driving?

He must contact his treating endocrinologist for clearance before resuming the same day
He must wait at least 45 minutes at a blood glucose ≥100 mg/dL before resuming (Correct answer)
He must wait at least 20 minutes and recheck glucose to confirm it remains ≥100 mg/dL
He may resume immediately once blood glucose is confirmed ≥100 mg/dL

Correct answer: He must wait at least 45 minutes at a blood glucose ≥100 mg/dL before resuming

The FMCSA ITDM exemption program requires that after a hypoglycemic episode (BG <100 mg/dL), the driver must not only raise blood glucose to ≥100 mg/dL but must also wait a minimum of 45 minutes at that level before resuming CMV operation. This stabilization period guards against rebound hypoglycemia. Simply achieving ≥100 mg/dL is insufficient; the 45-minute sustained threshold is mandatory.

Question 95: Which of the following conditions is generally considered disqualifying for a CMV driver unless a specific exemption is granted by the FMCSA?

Peripheral neuropathy with mild sensory loss in the feet but no motor deficit.
Benign positional vertigo that has been symptom-free for 3 months.
A history of a single, unprovoked seizure 6 years ago, with no anti-seizure medication used in the past 5 years.
A current clinical diagnosis of epilepsy, controlled with medication. (Correct answer)

Correct answer: A current clinical diagnosis of epilepsy, controlled with medication.

According to 49 CFR 391.41(b)(8), a person is not physically qualified to drive a CMV if they have an established medical history or clinical diagnosis of epilepsy or any other condition likely to cause loss of consciousness. While exemptions can be granted on a case-by-case basis, the regulation itself is disqualifying for a driver currently diagnosed with epilepsy, especially if they are on anti-seizure medication.

Question 96: A driver holds a federal medical exemption for insulin-treated diabetes mellitus (ITDM). How often must the exemption be renewed?

Every 6 months
Every 2 years
Every 3 years
Every year (Correct answer)

Correct answer: Every year

FMCSA ITDM exemptions must be renewed annually and require documentation of ongoing monitoring and glucose control.

Question 97: When a driver's BP is confirmed at 179/109 mmHg after two separate readings, the FMCSA guidance recommends:

Full 24-month certification
Deferral with no path to certification
One-time certificate up to 12 months with treatment initiated (Correct answer)
Permanent disqualification

Correct answer: One-time certificate up to 12 months with treatment initiated

Stage 2 hypertension (160-179/100-109) allows a single 12-month certificate to allow time for treatment and BP reduction before re-evaluation.

Question 98: To be eligible for the maximum 12-month medical certificate, a driver with insulin-treated diabetes mellitus (ITDM) must provide their treating clinician with what minimum duration of blood glucose self-monitoring records?

The preceding 6 months of records.
The preceding 3 months of records. (Correct answer)
The preceding 12 months of records.
The preceding 1 month of records.

Correct answer: The preceding 3 months of records.

FMCSA regulations require that an ITDM individual must provide at least the preceding 3 months of blood glucose self-monitoring records to their treating clinician for review. If a driver does not have 3 months of records, the medical examiner has the discretion to issue a certificate for up to 3 months to allow time to gather the required data.

Question 99: A commercial driver is diagnosed with ankylosing spondylitis affecting the thoracic and lumbar spine. Which finding would be most relevant to the medical examiner's certification decision?

HLA-B27 positive genetic marker
Elevated ESR and CRP laboratory values
History of uveitis associated with the condition
Fused spine with severely limited spinal mobility affecting the ability to look over the shoulder (Correct answer)

Correct answer: Fused spine with severely limited spinal mobility affecting the ability to look over the shoulder

Spinal fusion with severely limited mobility in ankylosing spondylitis can restrict the cervical range of motion needed for safe blind-spot checking.

Question 100: A CMV driver is found to have orthostatic proteinuria. The appropriate NRCME action is:

Permanent disqualification
Certify for 6 months only
Certify normally; orthostatic proteinuria is a benign condition (Correct answer)
Refer to nephrology immediately

Correct answer: Certify normally; orthostatic proteinuria is a benign condition

Orthostatic proteinuria is a benign condition in young individuals where protein appears in urine only in the upright position and carries no cardiovascular or renal risk.

Question 101: The NRCME examiner is reviewing a driver who takes gabapentin 600 mg three times daily for diabetic neuropathy pain. The primary safety concern is:

Sedation and dizziness that may impair driving ability (Correct answer)
Gabapentin's effect on peripheral nerve conduction
Gabapentin-induced hypertension
Risk of gabapentin-induced seizures on abrupt discontinuation

Correct answer: Sedation and dizziness that may impair driving ability

Gabapentin commonly causes dose-dependent sedation and dizziness, which can significantly impair a driver's alertness and reaction time while operating a CMV.

Question 102: A 48-year-old CMV driver presents for a certification exam. He reports having a stroke 18 months ago that affected his brainstem, with no subsequent seizures. He has completed rehabilitation, and a recent neurological evaluation shows no significant residual motor or cognitive deficits. According to FMCSA guidelines, what is the appropriate waiting period and maximum certification period for this driver?

A 1-year waiting period with a 1-year maximum certification. (Correct answer)
Permanent disqualification due to a history of stroke.
A 5-year waiting period with a 2-year maximum certification.
A 6-month waiting period with a 2-year certification.

Correct answer: A 1-year waiting period with a 1-year maximum certification.

FMCSA guidance specifies a minimum waiting period after a stroke. For a stroke that did not involve cortical or subcortical deficits and therefore has a low risk for seizures (like a brainstem or cerebellar stroke), the minimum waiting period is one year. After this period, if cleared by a neurologist, the driver may be certified for a maximum of one year at a time.

Question 103: When a driver has a Skill Performance Evaluation (SPE) certificate, what must the medical examiner document on the MER?

Nothing additional; SPE is handled entirely by the state
The SPE certificate number and the issuing FMCSA service center (Correct answer)
Only that the driver has a prosthetic limb
The driver's self-reported driving history

Correct answer: The SPE certificate number and the issuing FMCSA service center

The SPE certificate number and issuing center must be recorded on the MER to link the exemption to the physical examination record.

Question 104: A driver's 24-month certificate expires and they seek recertification. At recertification, what standard applies to evaluating their blood pressure?

Automatic renewal unless BP exceeds 200/110
The same standards as any new examination — current BP is evaluated against FMCSA thresholds (Correct answer)
Only the trend from prior exams matters, not the current reading
A more lenient standard since the driver has a prior certificate

Correct answer: The same standards as any new examination — current BP is evaluated against FMCSA thresholds

At every recertification, the driver is evaluated against current FMCSA medical standards as if it were a new examination.

Question 105: A CME is examining a driver taking a thiazide diuretic for hypertension. Which side effect is most relevant to commercial driving safety?

Hair thinning
Hypokalemia causing muscle weakness or cramps (Correct answer)
Increased appetite
Elevated cholesterol

Correct answer: Hypokalemia causing muscle weakness or cramps

Thiazide diuretics can cause hypokalemia leading to muscle weakness, cramps, and fatigue, all of which can impair a driver's ability to safely operate a commercial vehicle.

Question 106: A 61-year-old long-haul CDL driver takes clonidine 0.2 mg twice daily for hypertension. His BP is 128/78 at today's exam. During the history, he mentions occasional dizziness and lightheadedness when standing up after long rest stops. Which NRCME consideration is MOST directly relevant to his fitness for duty?

Mild dizziness is an expected and tolerable side effect of clonidine that does not affect certification when BP is controlled
Clonidine is listed as a prohibited medication for interstate commercial drivers under FMCSA regulations
Orthostatic hypotension from clonidine-induced vasodilation poses a direct safety risk relevant to commercial driving fitness (Correct answer)
The driver should be certified for 2 years since his BP is well below Stage 1 thresholds on treatment

Correct answer: Orthostatic hypotension from clonidine-induced vasodilation poses a direct safety risk relevant to commercial driving fitness

Clonidine is a centrally acting alpha-2 adrenergic agonist associated with both CNS sedation and orthostatic hypotension. Orthostatic hypotension causing symptomatic dizziness when transitioning from rest to upright posture — as occurs frequently during long-haul driving — represents a direct and quantifiable safety hazard. Clonidine is not categorically prohibited under FMCSA rules, but its side-effect profile must be evaluated in the context of driving safety. A 2-year certificate is inappropriate given both the hypertension treatment history and this reported symptom.

Question 107: Which of the following best describes the FMCSA's position on proteinuria discovered during a CMV driver's urinalysis?

Proteinuria findings are always ignored unless accompanied by hematuria
Proteinuria automatically triggers a Federal exemption review
Transient proteinuria from exertion or fever requires no further action if confirmed to be benign (Correct answer)
Any degree of proteinuria is permanently disqualifying

Correct answer: Transient proteinuria from exertion or fever requires no further action if confirmed to be benign

Transient, benign causes of proteinuria (such as orthostatic proteinuria or post-exercise proteinuria) that are confirmed to be non-pathological do not require disqualification.

Question 108: A driver was hospitalized 8 years ago for a first-episode psychotic break, treated with antipsychotics, achieved full remission, and has been off all psychotropic medications for 6 years with no recurrence. No current symptoms are noted during the examination. What is the most defensible certification approach?

Issue a standard 2-year certificate, since the driver has been asymptomatic and medication-free for 6 years, demonstrating durable remission
Obtain an independent psychiatric evaluation assessing current mental status, diagnosis specificity, and recurrence risk before making any certification decision (Correct answer)
Issue a 1-year certificate with the condition that the driver provide annual psychiatric clearance letters
Permanently disqualify the driver, as any documented history of psychosis is an automatic per se disqualifier under 49 CFR 391.41

Correct answer: Obtain an independent psychiatric evaluation assessing current mental status, diagnosis specificity, and recurrence risk before making any certification decision

A history of psychosis is not automatically disqualifying, nor does prolonged symptom-free duration guarantee safe certification without further inquiry. The medical examiner must obtain a specialist evaluation to assess the specific diagnosis (e.g., brief psychotic disorder vs. schizophrenia carry very different recurrence risks), current mental status, and whether the remission is truly durable. Certifying based solely on elapsed time without psychiatric input is not defensible under FMCSA standards.

Question 109: What is the minimum acceptable distant visual acuity in each eye (corrected or uncorrected) for a commercial driver under FMCSA standards?

20/40 (Correct answer)
20/60
20/50
20/100

Correct answer: 20/40

FMCSA requires distant visual acuity of at least 20/40 in each eye (with or without corrective lenses) for commercial driver qualification.

Question 110: A driver on a stable dose of an antidepressant for 2 years denies side effects. The medical examiner should additionally screen for:

Drug interactions with commercial diesel exhaust
Whether the medication is on the DEA controlled substance schedule
Residual depressive symptoms, sleep quality, and any cognitive side effects (Correct answer)
The prescribing physician's specialty certification

Correct answer: Residual depressive symptoms, sleep quality, and any cognitive side effects

Even with reported stability, the examiner should screen for residual symptoms, sleep disruption, and cognitive effects that could impair driving.

Question 111: A driver with controlled hypertension presents with sudden onset severe headache described as 'the worst of my life' two weeks ago that resolved. The appropriate NRCME response is:

Require documentation that a subarachnoid hemorrhage was excluded before certifying (Correct answer)
Certify if blood pressure is controlled today
Refer for an EEG to rule out seizure activity
Certify with 3-month follow-up only

Correct answer: Require documentation that a subarachnoid hemorrhage was excluded before certifying

A thunderclap headache described as 'worst of my life' is a red flag for subarachnoid hemorrhage; the examiner must confirm this was excluded by appropriate neuroimaging and lumbar puncture before certifying.

Question 112: Which finding on liver function tests is most suggestive of alcoholic liver disease in a CMV driver being evaluated?

Low serum albumin with normal transaminases
Isolated alkaline phosphatase elevation
AST:ALT ratio greater than 2:1 (Correct answer)
Elevated direct bilirubin with normal AST and ALT

Correct answer: AST:ALT ratio greater than 2:1

An AST:ALT ratio greater than 2:1 is a classic pattern seen in alcoholic liver disease due to alcohol's toxic effect on mitochondria elevating AST disproportionately.

Question 113: A driver holds a valid federal vision exemption and presents for a biennial physical. During the examination, the medical examiner discovers the driver now has progressive glaucoma with an intraocular pressure of 28 mmHg but visual acuity remains 20/40 in the exempt eye. What must the medical examiner do?

Contact FMCSA and report the change in medical status, as the exemption program requires reporting of new conditions that may affect driving safety (Correct answer)
Disqualify the driver immediately and revoke the federal vision exemption
Certify the driver for two years because the 20/40 acuity standard is still met in the exempted eye
Certify the driver for one year and notify FMCSA of the changed medical condition per exemption program requirements

Correct answer: Contact FMCSA and report the change in medical status, as the exemption program requires reporting of new conditions that may affect driving safety

Federal vision exemption holders must comply with ongoing monitoring requirements, and any new condition affecting the eyes or driving ability must be reported to FMCSA. The medical examiner cannot unilaterally revoke a federal exemption — that authority lies with FMCSA. The ME's obligation is to report the new condition (progressive glaucoma with elevated IOP) to FMCSA, which will then determine whether the exemption conditions are still satisfied. The ME should not simply certify as normal or ignore a materially changed ophthalmologic condition.

Question 114: A commercial driver with primary adrenal insufficiency (Addison's disease) has been stable on hydrocortisone 20 mg/5 mg (AM/PM split) and fludrocortisone 0.1 mg daily for 20 months. Blood pressure is 126/76 mmHg, serum sodium is 140 mEq/L, potassium is 4.1 mEq/L, and he has never had an adrenal crisis. He carries an IM hydrocortisone emergency kit and his endocrinologist documents 'well-controlled primary adrenal insufficiency, low adrenal crisis risk on current regimen.' What is the MOST appropriate certification decision?

Certify for 2 years; the condition is well-controlled and the driver is asymptomatic
Do not certify until the driver has maintained the identical replacement dose without adjustment for a minimum of 24 months
Certify for 1 year, contingent on stable replacement therapy, normal electrolytes and blood pressure, no crisis history, and documented possession of emergency glucocorticoids (Correct answer)
Permanently disqualify; adrenal insufficiency carries unpredictable acute incapacitation risk incompatible with CMV operation under any circumstances

Correct answer: Certify for 1 year, contingent on stable replacement therapy, normal electrolytes and blood pressure, no crisis history, and documented possession of emergency glucocorticoids

Stable, well-replaced primary adrenal insufficiency is not automatically disqualifying under FMCSA standards. The general physical qualification standard asks whether the condition currently impairs safe operation — and in a driver with stable electrolytes, normal blood pressure, no crisis episodes, and an emergency glucocorticoid kit, the current risk profile can support certification. However, annual (not biennial) certification is appropriate given the condition's potential for acute decompensation during illness or physiologic stress. A 2-year certificate provides insufficient oversight for adrenal-dependent homeostasis. Permanent disqualification is unwarranted in a well-managed case.

Question 115: The Unterberger (Fukuda) stepping test is used during neurological evaluation to assess which system?

Proprioceptive integrity of the lower limbs
Cerebellar coordination
Vestibular function and asymmetry (Correct answer)
Upper motor neuron pathways

Correct answer: Vestibular function and asymmetry

The Unterberger stepping test detects unilateral vestibular hypofunction; patients rotate toward the side of the lesion when marching in place with eyes closed.

Question 116: Which sleep apnea-related finding on history would most concern an NRCME examiner regarding a CMV driver's safety?

Excessive daytime sleepiness while driving (Correct answer)
Snoring reported by spouse
Apnea-hypopnea index of 10 on home sleep test
Neck circumference of 17 inches

Correct answer: Excessive daytime sleepiness while driving

Excessive daytime sleepiness while driving is a direct safety risk and the most disqualifying symptom for CMV operation.

Question 117: A 52-year-old driver with a documented history of coronary artery disease underwent percutaneous coronary intervention (PCI) with drug-eluting stent placement 5 months ago. He is asymptomatic, on dual antiplatelet therapy, and his cardiologist states he is 'doing well.' An exercise stress test 6 weeks post-PCI showed no ischemia at 10 METs. Under FMCSA cardiovascular standards, what is the minimum waiting period after PCI before the driver may be recertified for interstate CMV operation?

12 months, because drug-eluting stents require dual antiplatelet therapy for at least 12 months and this is an automatic disqualification period
30 days, provided the driver is asymptomatic and has a cardiologist clearance letter
6 months, as PCI with stenting requires a mandatory 6-month observation period per FMCSA Advisory Criteria
3 months, provided functional capacity is adequate and the driver is on appropriate medical therapy (Correct answer)

Correct answer: 3 months, provided functional capacity is adequate and the driver is on appropriate medical therapy

The FMCSA Cardiovascular Advisory Criteria (based on AHA/ACC guidance as interpreted by FMCSA) indicate that after PCI, drivers should wait a minimum of 3 months before returning to CMV operation, provided they are clinically stable, asymptomatic, have adequate functional capacity (generally ≥6 METs without ischemia), and are on appropriate therapy. There is no FMCSA-mandated 6-month or 12-month automatic waiting period specifically for PCI with DES. While dual antiplatelet therapy is standard for DES, it is not itself a disqualifying condition. The driver in this scenario, at 5 months post-PCI with a normal stress test, meets the minimum criteria for evaluation — the ME may certify with appropriate cardiovascular specialist input.

Question 118: A certified medical examiner is reviewing a driver who takes metformin and a GLP-1 receptor agonist for Type 2 diabetes. The driver has no history of hypoglycemia. Which regulatory pathway applies?

The driver must obtain a state-level diabetes waiver because GLP-1 agonists are classified as secretagogues.
The driver is disqualified until demonstrating HbA1c below 7.0% for two consecutive quarters.
The driver is medically qualified under standard FMCSA criteria, as these medications do not carry a significant intrinsic risk of hypoglycemia. (Correct answer)
The driver requires a Federal Diabetes Exemption because any anti-diabetic medication triggers the insulin-use disqualification standard.

Correct answer: The driver is medically qualified under standard FMCSA criteria, as these medications do not carry a significant intrinsic risk of hypoglycemia.

Metformin and GLP-1 receptor agonists (e.g., semaglutide, liraglutide) do not cause intrinsic hypoglycemia when used as monotherapy or in combination with each other, as neither mechanism directly stimulates insulin secretion independent of glucose. The Federal Diabetes Exemption Program applies specifically to insulin-using drivers. Drivers with well-controlled Type 2 diabetes managed by non-insulin agents with low hypoglycemia risk can be certified under standard FMCSA medical criteria without an exemption.

Question 119: Which sleep study type is considered the gold standard for diagnosing obstructive sleep apnea?

Type III home sleep apnea test (HSAT)
Type IV single-channel oximetry study
Type I attended in-laboratory polysomnography (Correct answer)
Type II unattended portable polysomnography

Correct answer: Type I attended in-laboratory polysomnography

Type I attended polysomnography in a sleep laboratory is the gold standard, measuring EEG, EMG, EOG, airflow, effort, and oxygen saturation simultaneously.

Question 120: During an NRCME physical exam, a driver with a BMI of 40 and neck circumference of 18 inches denies snoring or witnessed apneas. What is the best next step?

Immediately disqualify pending weight loss
Perform the Epworth Sleepiness Scale and refer for sleep study if score ≥10 (Correct answer)
Certify for 1 year and repeat exam if symptoms develop
Certify for 2 years since symptoms are denied

Correct answer: Perform the Epworth Sleepiness Scale and refer for sleep study if score ≥10

High BMI and large neck circumference are risk factors for OSA; the ESS and potential referral are warranted regardless of symptom denial.

NRCME Certified Medical Examiner Exam

The NRCME exam certifies medical professionals (MD, DO, DC, APN, APRN, NP, PA) to perform DOT physical examinations for commercial motor vehicle drivers. The exam contains 120 questions (100 scored + 20 unscored pilot items) and must be completed in 2 hours. A passing score of 71% is required.

120

Questions

120 min

Time Limit

71%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds